HEADER HYDROLASE 05-JUN-07 2Q6F TITLE CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE TITLE 2 IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FRAGMENT; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- COMPND 9 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3- COMPND 10 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE; COMPND 11 CHAIN: D, C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFECTIOUS BRONCHITIS VIRUS; SOURCE 3 ORGANISM_TAXID: 11120; SOURCE 4 STRAIN: M41; SOURCE 5 GENE: M41 3C-LIKE PROTEASE GENE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-1; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630 KEYWDS CORONAVIRUS; IBV; MAIN PROTEASE; 3C-LIKE PROTEINASE; MICHAEL ACCEPTOR KEYWDS 2 INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.XUE,H.T.YANG,F.XUE,M.BARTLAM,Z.H.RAO REVDAT 4 02-DEC-15 2Q6F 1 ATOM HETATM REMARK SEQRES REVDAT 4 2 1 VERSN REVDAT 3 24-FEB-09 2Q6F 1 VERSN REVDAT 2 25-MAR-08 2Q6F 1 JRNL REVDAT 1 12-FEB-08 2Q6F 0 JRNL AUTH X.XUE,H.YU,H.YANG,F.XUE,Z.WU,W.SHEN,J.LI,Z.ZHOU,Y.DING, JRNL AUTH 2 Q.ZHAO,X.C.ZHANG,M.LIAO,M.BARTLAM,Z.RAO JRNL TITL STRUCTURES OF TWO CORONAVIRUS MAIN PROTEASES: IMPLICATIONS JRNL TITL 2 FOR SUBSTRATE BINDING AND ANTIVIRAL DRUG DESIGN. JRNL REF J.VIROL. V. 82 2515 2008 JRNL REFN ISSN 0022-538X JRNL PMID 18094151 JRNL DOI 10.1128/JVI.02114-07 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 42003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4231 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4620 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 419 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-07. REMARK 100 THE RCSB ID CODE IS RCSB043207. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.22500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2Q6D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG10000, 0.1M HEPES PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER WITH ONE INHIBITOR REMARK 300 MOLECULE IN THE ACTIVE SITE OF EACH PROTOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z) REMARK 400 -4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2- REMARK 400 ENYL)-L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- REMARK 400 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: D, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 LYS A 214 REMARK 465 GLU A 215 REMARK 465 SER A 216 REMARK 465 SER A 217 REMARK 465 PHE A 218 REMARK 465 SER A 219 REMARK 465 GLN A 220 REMARK 465 GLY A 302 REMARK 465 GLY A 303 REMARK 465 VAL A 304 REMARK 465 ARG A 305 REMARK 465 LEU A 306 REMARK 465 GLN A 307 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 LYS B 214 REMARK 465 GLU B 215 REMARK 465 SER B 216 REMARK 465 SER B 217 REMARK 465 PHE B 218 REMARK 465 SER B 219 REMARK 465 GLN B 220 REMARK 465 GLY B 303 REMARK 465 VAL B 304 REMARK 465 ARG B 305 REMARK 465 LEU B 306 REMARK 465 GLN B 307 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 143 C20 PJE D 5 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 279 CB - CA - C ANGL. DEV. = -15.7 DEGREES REMARK 500 SER A 279 N - CA - CB ANGL. DEV. = 14.2 DEGREES REMARK 500 ASP A 280 CB - CG - OD1 ANGL. DEV. = 8.9 DEGREES REMARK 500 ASP A 280 CB - CG - OD2 ANGL. DEV. = -8.4 DEGREES REMARK 500 ASP A 280 N - CA - C ANGL. DEV. = -18.8 DEGREES REMARK 500 SER A 279 CA - C - N ANGL. DEV. = -19.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 41 1.61 -66.18 REMARK 500 PHE A 46 -167.63 -114.54 REMARK 500 ALA A 136 -156.32 -117.67 REMARK 500 ASN A 167 36.55 70.69 REMARK 500 ASP A 280 126.17 173.23 REMARK 500 LEU B 27 -169.49 -162.35 REMARK 500 HIS B 41 7.28 -65.89 REMARK 500 PHE B 46 -166.34 -119.90 REMARK 500 ALA B 136 -156.28 -118.83 REMARK 500 HIS B 162 -50.91 -120.08 REMARK 500 ASN B 167 45.41 70.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 461 DISTANCE = 5.19 ANGSTROMS REMARK 525 HOH A 560 DISTANCE = 9.43 ANGSTROMS REMARK 525 HOH A 611 DISTANCE = 8.67 ANGSTROMS REMARK 525 HOH A 614 DISTANCE = 5.60 ANGSTROMS REMARK 525 HOH A 620 DISTANCE = 11.15 ANGSTROMS REMARK 525 HOH A 621 DISTANCE = 10.93 ANGSTROMS REMARK 525 HOH A 632 DISTANCE = 5.05 ANGSTROMS REMARK 525 HOH A 647 DISTANCE = 5.66 ANGSTROMS REMARK 525 HOH B 470 DISTANCE = 5.61 ANGSTROMS REMARK 525 HOH B 486 DISTANCE = 6.08 ANGSTROMS REMARK 525 HOH B 516 DISTANCE = 5.05 ANGSTROMS REMARK 525 HOH B 530 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH B 535 DISTANCE = 5.16 ANGSTROMS REMARK 525 HOH B 537 DISTANCE = 5.30 ANGSTROMS REMARK 525 HOH B 551 DISTANCE = 6.81 ANGSTROMS REMARK 525 HOH B 560 DISTANCE = 9.99 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q6D RELATED DB: PDB REMARK 900 RELATED ID: 2Q6G RELATED DB: PDB DBREF 2Q6F A 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 DBREF 2Q6F B 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 DBREF 2Q6F C 1 6 PDB 2Q6F 2Q6F 1 6 DBREF 2Q6F D 1 6 PDB 2Q6F 2Q6F 1 6 SEQADV 2Q6F GLY A -1 UNP Q3Y5H1 INSERTION SEQADV 2Q6F SER A 0 UNP Q3Y5H1 INSERTION SEQADV 2Q6F GLY B -1 UNP Q3Y5H1 INSERTION SEQADV 2Q6F SER B 0 UNP Q3Y5H1 INSERTION SEQRES 1 A 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 A 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 A 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 A 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 A 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 A 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 A 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 A 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 A 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 A 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 A 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 A 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 A 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 A 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 A 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 A 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 A 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 A 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 A 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 A 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 A 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 A 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 A 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN SEQRES 1 B 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 B 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 B 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 B 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 B 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 B 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 B 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 B 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 B 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 B 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 B 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 B 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 B 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 B 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 B 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 B 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 B 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 B 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 B 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 B 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 B 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 B 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 B 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN SEQRES 1 D 6 02J ALA VAL LEU PJE 010 SEQRES 1 C 6 02J ALA VAL LEU PJE 010 HET 02J D 1 8 HET PJE D 5 13 HET 010 D 6 8 HET 02J C 1 8 HET PJE C 5 13 HET 010 C 6 8 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL FORMUL 3 02J 2(C5 H5 N O3) FORMUL 3 PJE 2(C9 H14 N2 O3) FORMUL 3 010 2(C7 H8 O) FORMUL 5 HOH *419(H2 O) HELIX 1 1 SER A 10 LYS A 15 1 6 HELIX 2 2 HIS A 41 GLY A 44 5 4 HELIX 3 3 ASP A 49 ALA A 58 1 10 HELIX 4 4 ASN A 59 PHE A 63 5 5 HELIX 5 5 PHE A 179 TYR A 183 5 5 HELIX 6 6 VAL A 198 VAL A 213 1 16 HELIX 7 7 SER A 230 SER A 239 1 10 HELIX 8 8 SER A 249 GLY A 260 1 12 HELIX 9 9 ASP A 262 GLN A 276 1 15 HELIX 10 10 THR A 293 GLN A 300 1 8 HELIX 11 11 SER B 10 LYS B 15 1 6 HELIX 12 12 HIS B 41 GLY B 44 5 4 HELIX 13 13 ASP B 49 LEU B 57 1 9 HELIX 14 14 ASN B 59 PHE B 63 5 5 HELIX 15 15 PHE B 179 TYR B 183 5 5 HELIX 16 16 VAL B 198 VAL B 213 1 16 HELIX 17 17 SER B 230 ASN B 241 1 12 HELIX 18 18 SER B 249 GLY B 260 1 12 HELIX 19 19 ASP B 262 GLN B 276 1 15 HELIX 20 20 THR B 293 GLN B 300 1 8 SHEET 1 A 6 GLU A 64 VAL A 66 0 SHEET 2 A 6 ILE A 17 TYR A 22 -1 N SER A 21 O GLU A 64 SHEET 3 A 6 ASN A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 4 A 6 SER A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 5 A 6 VAL A 84 THR A 89 -1 O LEU A 85 N CYS A 38 SHEET 6 A 6 VAL A 75 LYS A 81 -1 N VAL A 76 O GLN A 88 SHEET 1 B 5 TYR A 99 PHE A 101 0 SHEET 2 B 5 VAL A 154 LEU A 165 1 O PHE A 157 N LYS A 100 SHEET 3 B 5 VAL A 146 GLU A 151 -1 N GLY A 147 O PHE A 158 SHEET 4 B 5 SER A 109 TYR A 116 -1 N THR A 111 O PHE A 148 SHEET 5 B 5 THR A 119 THR A 127 -1 O TYR A 124 N ILE A 112 SHEET 1 C 3 TYR A 99 PHE A 101 0 SHEET 2 C 3 VAL A 154 LEU A 165 1 O PHE A 157 N LYS A 100 SHEET 3 C 3 LEU A 169 THR A 173 -1 O LEU A 169 N LEU A 165 SHEET 1 D 7 THR B 72 LEU B 73 0 SHEET 2 D 7 GLU B 64 VAL B 66 -1 N VAL B 65 O LEU B 73 SHEET 3 D 7 ILE B 17 TYR B 22 -1 N SER B 21 O GLU B 64 SHEET 4 D 7 ASN B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 D 7 SER B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 VAL B 84 THR B 89 -1 O LEU B 85 N CYS B 38 SHEET 7 D 7 VAL B 75 LYS B 81 -1 N LYS B 81 O VAL B 84 SHEET 1 E 5 TYR B 99 PHE B 101 0 SHEET 2 E 5 VAL B 154 LEU B 165 1 O PHE B 157 N LYS B 100 SHEET 3 E 5 VAL B 146 GLU B 151 -1 N ASN B 149 O ASN B 156 SHEET 4 E 5 SER B 109 TYR B 116 -1 N THR B 111 O PHE B 148 SHEET 5 E 5 THR B 119 THR B 127 -1 O TYR B 124 N ILE B 112 SHEET 1 F 3 TYR B 99 PHE B 101 0 SHEET 2 F 3 VAL B 154 LEU B 165 1 O PHE B 157 N LYS B 100 SHEET 3 F 3 LEU B 169 THR B 173 -1 O LEU B 169 N LEU B 165 LINK C41 02J C 1 N ALA C 2 1555 1555 1.34 LINK C LEU C 4 N5 PJE C 5 1555 1555 1.33 LINK C22 PJE C 5 O 010 C 6 1555 1555 1.47 LINK C41 02J D 1 N ALA D 2 1555 1555 1.34 LINK C LEU D 4 N5 PJE D 5 1555 1555 1.33 LINK C22 PJE D 5 O 010 D 6 1555 1555 1.45 SITE 1 AC1 16 HIS A 41 PHE A 138 ALA A 140 GLY A 141 SITE 2 AC1 16 CYS A 143 HIS A 161 HIS A 162 LEU A 163 SITE 3 AC1 16 GLU A 164 HIS A 170 GLU A 186 GLU A 187 SITE 4 AC1 16 VAL A 188 ALA A 189 SER A 256 GLY A 260 SITE 1 AC2 15 ASN B 25 ASN B 26 LEU B 27 HIS B 41 SITE 2 AC2 15 PHE B 138 GLY B 141 ALA B 142 CYS B 143 SITE 3 AC2 15 HIS B 161 HIS B 162 LEU B 163 GLU B 164 SITE 4 AC2 15 HIS B 170 GLU B 187 VAL B 188 CRYST1 53.175 54.502 66.719 111.06 104.31 91.33 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018806 0.000437 0.005357 0.00000 SCALE2 0.000000 0.018353 0.007467 0.00000 SCALE3 0.000000 0.000000 0.016700 0.00000 MASTER 356 0 6 20 29 0 8 6 0 0 0 50 END